KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Becton Dickinson (BDX) Gains from Sales and Divestitures (2012 - 2014)

Becton Dickinson (BDX) reported Gains from Sales and Divestitures of $80000.0 for Q3 2014, down 82.49% year-over-year from $457000.0 in Q3 2013, and down 82.49% on a QoQ basis from $457000.0 in Q3 2013.

Becton Dickinson (BDX) has 3 years of Gains from Sales and Divestitures data on file, last reported at $80000.0 in Q3 2014.

  • Quarterly Gains from Sales and Divestitures fell 82.49% year-over-year to $80000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $80000.0 (down 82.49% YoY) and the FY2014 annual result came in at $80000.0, down 82.49% from the prior year.
  • Gains from Sales and Divestitures fell to $80000.0 in Q3 2014 per BDX's latest filing, from $457000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $457000.0 in Q3 2013 and bottomed at $78086.0 in Q3 2012.
  • The 3-year median for Gains from Sales and Divestitures is $80000.0 (2014), against an average of $205028.7.
  • The widest annual swing landed in 2013, when Gains from Sales and Divestitures soared 485.25%; it then sank 82.49% in 2014.
  • Tracing BDX's Gains from Sales and Divestitures over 3 years: stood at $78086.0 in 2012, then soared by 485.25% to $457000.0 in 2013, then slumped by 82.49% to $80000.0 in 2014.
  • Per Business Quant, the three latest BDX Gains from Sales and Divestitures figures stand at $80000.0 (Q3 2014), $457000.0 (Q3 2013), and $78086.0 (Q3 2012).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2014 80,000.00
Sep 30, 2014 80,000.00
Sep 30, 2013 457,000.00
Sep 30, 2013 457,000.00
Sep 30, 2012 78,086.00
Sep 30, 2012 78,086.00